COVID-19 :
It is known that mother cells are used as treatments for cancer, Parkinson’s disease, spinal cord injury, type 1 diabetes or Alzheimer’s disease, among others. How could it be otherwise, nowadays too These umbilical cord body types have been revealed to be able to help people with the disease against COVID-19.
This information was notified by the doctor Camilo Ricordi, Director of Diabetes Research Institute (DRI) and of University of Miami Miller School of Medicine Cell Transplant Center, and its team of international collaborators (‘L’Alliance Cure ‘), who carried out an innovative test which showed that “Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSC) Infusions Safely Reduce Risk of Death and Speed Up Recovery Time for Most Severely Covid-19 Patients”, as published in the magazine “Translational Stem Cell Medicine” (MCTS).
A study with 24 patients
The study was cleared by the United States Food and Drug Administration (FDA) in April and started with «L’Alliance Cure», nail organisation non-profit, led by Ricordi, These include scientific researchers who share knowledge with each other that serves to accelerate the cure of all kinds of diseases.
At the start of the pandemic, Ricordi created the ‘Mini-Manhattan Project’, which ultimately produced important results on the possible treatment of umbilical cord stem cells to treat COVID-19 disease in people with severe consequences.
To conduct the study, the researchers analyzed the cases of 24 hospital patients at the University of Miami Tower and Jackson Memorial Hospital they had developed severe acute respiratory distress because of coronavirus. As part of the trial, scientists they tried giving two infusions of mesenchymal stem cells and placebos to hospital patients several days apart.
Anti-inflammatory effect of stem cells
“It’s like the technology of a smart pump in the lungs to restore the normal immune response and reverse life-threatening complications”, Ricordi notes in the study.
“Our results confirm the powerful anti-inflammatory and immunomodulatory effect of UC-MSC. These cells clearly inhibited the “cytokine storm” a hallmark of severe COVID-19. Add Giacomo Lanzoni, lead author of the research.
“The findings are critically important not only for COVID-19, but also for other diseases characterized by aberrant and hyper-inflammatory immune responses, such as autoimmune type 1 diabetes. We are eager to apply these cells in clinical trials to halt the progression of type 1 diabetes, ”he concludes. Lanzoni in “Translational Stem Cell Medicine” (MCTS)..
–
